Related Experiment Videos
CCT2 Promotes Immune Escape in Colorectal Cancer by Regulating the JAK1-STAT3-PD-L1 Axis
Liqiang Gu1, Shaofei Li1, Yichao Tang1
1Department of Colorectal Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
Journal of Gastroenterology and Hepatology
|August 12, 2026
Summary
Chaperonin containing TCP1 subunit 2 (CCT2) promotes colorectal cancer immune evasion by upregulating programmed cell death ligand 1 (PD-L1) through the JAK1-STAT3 pathway. Targeting CCT2 may enhance colorectal cancer immunotherapy.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Colorectal cancer (CRC) poses a significant global health challenge.
- Current immunotherapies, like immune checkpoint inhibitors, show limited efficacy in microsatellite-stable CRC.
- Understanding CRC immune evasion mechanisms is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the molecular mechanisms behind colorectal cancer's immune evasion.
- To identify key molecular targets for improving CRC immunotherapy.
Main Methods:
- Bioinformatics and machine learning for target screening.
- RT-PCR, Western blot, ELISA, and various cell-based assays (EdU, TUNEL, Transwell, wound healing, LDH) for molecular and cellular analysis.
- In vivo studies using xenograft mouse models and immunohistochemistry for validation.
Main Results:
- CCT2 was identified as a core gene in CRC with significantly increased expression in tumor tissues.
- CCT2 knockdown suppressed CRC cell proliferation, invasion, and migration in vitro and in vivo.
- CCT2 expression positively correlated with PD-L1 levels in CRC patients.
- CCT2 knockdown enhanced CD8+ T cell activation and proinflammatory cytokine secretion by downregulating PD-L1 via the JAK1-STAT3 pathway.
Conclusions:
- Upregulated CCT2 drives colorectal cancer immune escape by modulating the JAK1-STAT3-PD-L1 axis.
- CCT2 represents a potential therapeutic target for enhancing colorectal cancer treatment.
Related Concept Videos
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...